Kymera Therapeutics Inc (KYMR)
34.05
-0.19
(-0.55%)
USD |
NASDAQ |
May 24, 16:00
34.08
+0.03
(+0.09%)
After-Hours: 20:00
Kymera Therapeutics Price to Book Value: 2.938 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 2.938 |
| May 23, 2024 | 2.954 |
| May 22, 2024 | 3.08 |
| May 21, 2024 | 3.047 |
| May 20, 2024 | 3.107 |
| May 17, 2024 | 3.015 |
| May 16, 2024 | 3.071 |
| May 15, 2024 | 3.101 |
| May 14, 2024 | 3.027 |
| May 13, 2024 | 3.310 |
| May 10, 2024 | 3.270 |
| May 09, 2024 | 3.331 |
| May 08, 2024 | 3.322 |
| May 07, 2024 | 3.316 |
| May 06, 2024 | 3.304 |
| May 03, 2024 | 3.227 |
| May 02, 2024 | 3.132 |
| May 01, 2024 | 3.127 |
| April 30, 2024 | 2.900 |
| April 29, 2024 | 2.990 |
| April 26, 2024 | 2.879 |
| April 25, 2024 | 2.877 |
| April 24, 2024 | 3.038 |
| April 23, 2024 | 3.081 |
| April 22, 2024 | 2.964 |
| Date | Value |
|---|---|
| April 19, 2024 | 2.931 |
| April 18, 2024 | 3.030 |
| April 17, 2024 | 2.912 |
| April 16, 2024 | 2.927 |
| April 15, 2024 | 2.967 |
| April 12, 2024 | 3.069 |
| April 11, 2024 | 3.21 |
| April 10, 2024 | 3.048 |
| April 09, 2024 | 3.244 |
| April 08, 2024 | 3.138 |
| April 05, 2024 | 3.140 |
| April 04, 2024 | 3.126 |
| April 03, 2024 | 3.203 |
| April 02, 2024 | 3.247 |
| April 01, 2024 | 3.401 |
| March 31, 2024 | |
| March 28, 2024 | 6.220 |
| March 27, 2024 | 6.215 |
| March 26, 2024 | 6.110 |
| March 25, 2024 | 6.112 |
| March 22, 2024 | 6.300 |
| March 21, 2024 | 6.316 |
| March 20, 2024 | 6.24 |
| March 19, 2024 | 6.122 |
| March 18, 2024 | 6.084 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.539
Minimum
Oct 27 2023
14.24
Maximum
Aug 28 2020
5.349
Average
4.230
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group Inc | 8.350 |
| Iovance Biotherapeutics Inc | 4.119 |
| Immunic Inc | 1.347 |
| Protagonist Therapeutics Inc | 3.182 |
| Ovid Therapeutics Inc | 2.719 |
Price to Book Value Related Metrics
| PS Ratio | 26.37 |
| Price | 34.05 |
| Earnings Yield | -7.37% |
| Market Cap | 2.089B |